Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.

Löwe LC, Gaser C, Franke K; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2016 Jul 13;11(7):e0157514. doi: 10.1371/journal.pone.0157514. eCollection 2016.

2.
3.

Temporal course of neurodegenerative effects on cognition in old age.

Wilson RS, Capuano AW, Bennett DA, Schneider JA, Boyle PA.

Neuropsychology. 2016 Jul;30(5):591-9. doi: 10.1037/neu0000282. Epub 2016 Apr 25.

PMID:
27111293
4.
5.

Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging.

Liu S, Cai W, Pujol S, Kikinis R, Feng DD; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2016 Feb 23;8:23. doi: 10.3389/fnagi.2016.00023. eCollection 2016.

6.

Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Jack CR Jr, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ.

Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18. Review.

7.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

8.

Transcranial Magnetic Stimulation to Address Mild Cognitive Impairment in the Elderly: A Randomized Controlled Study.

Drumond Marra HL, Myczkowski ML, Maia Memória C, Arnaut D, Leite Ribeiro P, Sardinha Mansur CG, Lancelote Alberto R, Boura Bellini B, Alves Fernandes da Silva A, Tortella G, Ciampi de Andrade D, Teixeira MJ, Forlenza OV, Marcolin MA.

Behav Neurol. 2015;2015:287843. doi: 10.1155/2015/287843. Epub 2015 Jun 16.

9.

Differences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairment.

Yi D, Choe YM, Byun MS, Sohn BK, Seo EH, Han J, Park J, Woo JI, Lee DY.

Front Aging Neurosci. 2015 Feb 19;7:15. doi: 10.3389/fnagi.2015.00015. eCollection 2015.

10.

'Hearts and minds': association, causation and implication of cognitive impairment in heart failure.

Cannon JA, McMurray JJ, Quinn TJ.

Alzheimers Res Ther. 2015 Feb 27;7(1):22. doi: 10.1186/s13195-015-0106-5. eCollection 2015.

11.

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.

Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 17;84(7):729-37. doi: 10.1212/WNL.0000000000001231. Epub 2015 Jan 21.

12.

Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies.

Kang JH, Ryoo NY, Shin DW, Trojanowski JQ, Shaw LM.

Korean J Physiol Pharmacol. 2014 Dec;18(6):447-56. doi: 10.4196/kjpp.2014.18.6.447. Epub 2014 Dec 30. Review.

13.

The diagnosis and management of mild cognitive impairment: a clinical review.

Langa KM, Levine DA.

JAMA. 2014 Dec 17;312(23):2551-61. doi: 10.1001/jama.2014.13806. Review.

14.

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.

Donaghy PC, McKeith IG.

Alzheimers Res Ther. 2014 Jul 21;6(4):46. doi: 10.1186/alzrt274. eCollection 2014. Review.

15.

Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's disease.

Kantarci K.

Front Aging Neurosci. 2014 Nov 13;6:316. doi: 10.3389/fnagi.2014.00316. eCollection 2014. Review.

16.

Primary age-related tauopathy (PART): a common pathology associated with human aging.

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT.

Acta Neuropathol. 2014 Dec;128(6):755-66. doi: 10.1007/s00401-014-1349-0. Epub 2014 Oct 28.

17.

White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.

Kantarci K, Schwarz CG, Reid RI, Przybelski SA, Lesnick TG, Zuk SM, Senjem ML, Gunter JL, Lowe V, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr.

JAMA Neurol. 2014 Dec;71(12):1547-54. doi: 10.1001/jamaneurol.2014.1482.

18.

Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations.

Acosta-Cabronero J, Nestor PJ.

Front Aging Neurosci. 2014 Oct 2;6:266. doi: 10.3389/fnagi.2014.00266. eCollection 2014. Review.

19.

Mild cognitive impairment and mild dementia: a clinical perspective.

Knopman DS, Petersen RC.

Mayo Clin Proc. 2014 Oct;89(10):1452-9. doi: 10.1016/j.mayocp.2014.06.019.

20.

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA.

JAMA Neurol. 2014 Nov;71(11):1379-85. doi: 10.1001/jamaneurol.2014.2031.

Items per page

Supplemental Content

Write to the Help Desk